Two-Year Real-World Results for Aflibercept Using the Treat-and-Extend Regimen in Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

被引：0
|
作者：
Chu-Hsuan Huang
Tso-Ting Lai
Chang-Hao Yang
Yi-Ting Hsieh
机构：
[1] Cathay General Hospital,Department of Ophthalmology
[2] National Tsing Hua University,School of Medicine
[3] National Taiwan University Hospital,Department of Ophthalmology
[4] National Taiwan University,Department of Ophthalmology, College of Medicine
来源：
Ophthalmology and Therapy | 2024年 / 13卷
关键词：
Aflibercept; Age-related macular degeneration; Polypoidal choroidal vasculopathy; Treat-and-extend regimen; Vascular endothelial growth factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：385 / 396
页数：11
相关论文
共 50 条
  • [1] Two-Year Real-World Results for Aflibercept Using the Treat-and-Extend Regimen in Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy
    Huang, Chu-Hsuan
    Lai, Tso-Ting
    Yang, Chang-Hao
    Hsieh, Yi-Ting
    OPHTHALMOLOGY AND THERAPY, 2024, 13 (01) : 385 - 396
  • [2] Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy
    Dan Călugăru
    Mihai Călugăru
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 221 - 223
  • [3] Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy
    Morimoto, Masahiro
    Matsumoto, Hidetaka
    Mimura, Kensuke
    Akiyama, Hideo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 255 (10) : 1891 - 1897
  • [4] Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy
    Calugaru, Dan
    Calugaru, Mihai
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (01) : 221 - 223
  • [5] Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy
    Masahiro Morimoto
    Hidetaka Matsumoto
    Kensuke Mimura
    Hideo Akiyama
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2017, 255 : 1891 - 1897
  • [6] Two-year outcome of treat-and-extend aflibercept after ranibizumab in age-related macular degeneration and polypoidal choroidal vasculopathy patients
    Azuma, Keiko
    Asaoka, Ryo
    Matsuda, Aya
    Lee, Jihee
    Shimizu, Kimiko
    Inui, Hiroko
    Murata, Hiroshi
    Ogawa, Asako
    Yamamoto, Motoshi
    Inoue, Tatsuya
    Obata, Ryo
    CLINICAL OPHTHALMOLOGY, 2018, 12 : 1589 - 1597
  • [7] Reply to the letter to the editor: Two-year results of treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy
    Masahiro Morimoto
    Hidetaka Matsumoto
    Kensuke Mimura
    Hideo Akiyama
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2018, 256 : 225 - 226
  • [8] Reply to the letter to the editor: Two-year results of treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy
    Morimoto, Masahiro
    Matsumoto, Hidetaka
    Mimura, Kensuke
    Akiyama, Hideo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2018, 256 (01) : 225 - 226
  • [9] Impact of COVID-19 on a real-world treat-and-extend regimen with aflibercept for neovascular age-related macular degeneration
    Nanji, Keean
    Kennedy, Kevin
    Fung, Matthew
    Xie, Jim
    Hatamnejad, Amin
    Garg, Sunir J.
    Wykoff, Charles C.
    Chaudhary, Varun
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2025, 60 (01): : e92 - e99
  • [10] Two-year outcome of aflibercept for treatment-naive patient with neovascular age-related macular degeneration using modified treat-and-extend regimen
    Ohnaka, Masayuki
    Nagai, Yoshimi
    Kimura, Motoki
    Chihara, Tomoyuki
    Nakagawa, Kazuki
    Fujita, Kyoko
    Takahashi, Kanji
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
12345